<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pmed</journal-id><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0030321</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Mental Health</subject>
          <subject>Pediatrics and Child Health</subject>
        </subj-group>
        <subj-group subj-group-type="System Taxonomy">
          <subject>Adolescent psychiatry</subject>
          <subject>Child psychiatry</subject>
          <subject>Mood disorders (including depression)</subject>
          <subject>Pediatrics</subject>
          <subject>Psychiatry</subject>
        </subj-group>
      </article-categories><title-group><article-title>Questionable Advertising of Psychotropic Medications and Disease Mongering</article-title><alt-title alt-title-type="running-head">Correspondence</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Lacasse</surname>
            <given-names>Jeffrey R</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="n1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Leo</surname>
            <given-names>Jonathan</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">
				<label>1</label>
				
				<addr-line>Florida State University, Tallahassee, Florida, United States of America</addr-line>
				
			</aff><aff id="aff2">
				<label>2</label>
				
				<addr-line>Lincoln Memorial University, Harrogate, Tennesseee, United States of America</addr-line>
				
			</aff><author-notes>
        <corresp id="n1">(E-mail: 
					<email xlink:type="simple">jeffreylacasse@comcast.net</email>)
				</corresp>
      <fn fn-type="conflict" id="n2">
        <p>
						 The authors have declared that no competing interests exist.
					</p>
      </fn></author-notes><pub-date pub-type="ppub">
        <month>7</month>
        <year>2006</year>
      </pub-date><pub-date pub-type="epub">
        <day>25</day>
        <month>7</month>
        <year>2006</year>
      </pub-date><volume>3</volume><issue>7</issue><elocation-id>e321</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2006</copyright-year><copyright-holder>Lacasse and Leo</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article page="e185" related-article-type="companion" vol="3" xlink:href="info:doi/10.1371/journal.pmed.0030185" xlink:title="essay" xlink:type="simple">
				<article-title>The Latest Mania: Selling Bipolar Disorder</article-title>
			</related-article><funding-group><funding-statement>
					The authors received no specific funding for this article.
				</funding-statement></funding-group></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>David Healy raises intriguing questions regarding the rapid increase in bipolar diagnoses and the use of “mood stabilizing” medications [<xref ref-type="bibr" rid="pmed-0030321-b1">1</xref>]. Although this phenomenon is multifactorial, surely consumer advertising has played a role.
			</p>
      <p>A widely disseminated advertising campaign for aripiprazole (Abilify) claimed that it worked in the brain “like a thermostat to restore balance” [<xref ref-type="bibr" rid="pmed-0030321-b2">2</xref>]. Interestingly, the Abilify product Web sites for schizophrenia and bipolar disorder both used virtually identical explanations to describe both neuropathology and the drug's mechanism of action. Print advertisements promoting aripiprazole for bipolar disorder claimed: “When activity of key brain chemicals is too high, Abilify lowers it…. When activity of key brain chemicals is too low, Abilify raises it” [<xref ref-type="bibr" rid="pmed-0030321-b3">3</xref>].
			</p>
      <p>Since the product information insert approved by the United States Food and Drug Administration (FDA) lists the mechanism of action as “unknown” [<xref ref-type="bibr" rid="pmed-0030321-b4">4</xref>], this advertisement is debatable. It is further questionable whether the complexities of treating bipolar disorder (with its unknown etiology and well-known heterogeneity in response to treatment) are accurately portrayed as a reliable, mechanical thermostat. However, consumers are likely to find such advertisements compelling.
			</p>
      <p>Regarding unipolar depression, we recently argued [<xref ref-type="bibr" rid="pmed-0030321-b5">5</xref>] that antidepressant manufacturers commonly advertise their products by claiming that depression is caused by a lack of serotonin and that selective serotonin reuptake inhibitors normalize this deficiency, a claim not congruent with the peer-reviewed literature or FDA-approved product information. We have not received any academic objections to our article, but several prominent psychiatrists have affirmed our conclusions. For instance, Wayne Goodman, Chair of the FDA Psychopharmacological Advisory Committee, admitted that the serotonergic theory of depression is a “useful metaphor”—and one that he never uses within his own psychiatric practice [<xref ref-type="bibr" rid="pmed-0030321-b6">6</xref>].
			</p>
      <p>The presentation of metaphorical explanations as scientific consensus in consumer advertising has not been publicly addressed by the relevant professional associations. In fact, we observe that a cooperative relationship exists between industry and medical facilities, even highly esteemed ones: the Mayo Clinic Web site on depression, sponsored by Wyeth Pharmaceuticals (makers of venlafaxine) explains the treatment of depression via the serotonin metaphor [<xref ref-type="bibr" rid="pmed-0030321-b7">7</xref>].
			</p>
      <p>Such bioreductionistic and highly arguable advertisements for psychiatric treatments imply much about the disorder they are licensed for. As Dr. Healy suggests, consumers who view such advertisements are likely to characterize their problems in a manner congruent with industry promotion and to request well-advertised pharmaceuticals as treatment. At a bare minimum, increased medicalization will result; in some cases, disease mongering may indeed be an appropriate characterization.</p>
      <p>Such consumer advertising is only possible in the absence of vigorous government regulation [<xref ref-type="bibr" rid="pmed-0030321-b8">8</xref>] or outcry from professional associations. We hypothesize that their combined silence significantly contributes to the process of disease mongering.
			</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pmed-0030321-b1">
        <label>1</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Healy</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The latest mania: Selling bipolar disorder.</article-title>
          <source>PLoS Med</source>
          <year>2006</year>
          <volume>3</volume>
          <fpage>e185</fpage>
          <comment>doi: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030185" xlink:type="simple">10.1371/journal.pmed.0030185</ext-link></comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030321-b2">
        <label>2</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <collab xlink:type="simple">Otsuka America Pharmaceutical</collab>
          <article-title>Abilify consumer advertising website.</article-title>
          <year>2006</year>
          <month>1</month>
          <day>17</day>
          <comment>
							<ext-link ext-link-type="uri" xlink:href="http://dtca.net/Pics/ABILIFY%20CACHE.htm" xlink:type="simple">http://dtca.net/Pics/ABILIFY%20CACHE.htm</ext-link>. Accessed 7 June 2006
						</comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030321-b3">
        <label>3</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <collab xlink:type="simple">Otsuka America Pharmaceutical</collab>
          <article-title>How Abilify is thought to work [advertisement].</article-title>
          <source>People</source>
          <year>2005</year>
          <month>11</month>
          <day>28</day>
          <comment>Available: 
							<ext-link ext-link-type="uri" xlink:href="http://dtca.net/Pics/aripadvert.jpg" xlink:type="simple">http://dtca.net/Pics/aripadvert.jpg</ext-link>. Accessed 7 June 2006
						</comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030321-b4">
        <label>4</label>
        <nlm-citation publication-type="book" xlink:type="simple">
          <collab xlink:type="simple">Otsuka America Pharmaceutical</collab>
          <source>Abilify: Full product information</source>
          <year>2005</year>
          <month>12</month>
          <publisher-loc>Rockville (Maryland)</publisher-loc>
          <publisher-name>Otsuka America Pharmaceutical</publisher-name>
          <comment>
							<ext-link ext-link-type="uri" xlink:href="http://www.bms.com/cgi-bin/anybin.pl?sql=select%20PPI%20from%20TB_PRODUCT_PPI%20where%20PPI_SEQ=101&amp;key=PPI" xlink:type="simple">http://www.bms.com/cgi-bin/anybin.pl?sql=select%20PPI%20from%20TB_PRODUCT_PPI%20where%20PPI_SEQ=101&amp;key=PPI</ext-link>. Accessed 5 June 2006
						</comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030321-b5">
        <label>5</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Lacasse</surname>
              <given-names>JR</given-names>
            </name>
            <name name-style="western">
              <surname>Leo</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Serotonin and depression: A disconnect between the advertisements and the scientific literature.</article-title>
          <source>PLoS Med</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>e392</fpage>
          <comment>doi: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0020392" xlink:type="simple">10.1371/journal.pmed.0020392</ext-link></comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030321-b6">
        <label>6</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <collab xlink:type="simple">Anonymous</collab>
          <article-title>Television adverts for antidepressants cause anxiety.</article-title>
          <source>New Scientist</source>
          <year>2005</year>
          <month>11</month>
          <day>12</day>
          <comment>Available: 
							<ext-link ext-link-type="uri" xlink:href="http://www.newscientist.com/article/mg18825252.500.html" xlink:type="simple">http://www.newscientist.com/article/mg18825252.500.html</ext-link>. Accessed 22 April 2006
					</comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030321-b7">
        <label>7</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <collab xlink:type="simple">Mayo Clinic</collab>
          <article-title>Video: Antidepressants: How they relieve depression.</article-title>
          <source>Mayo Clinic</source>
          <year>2006</year>
          <comment>Available: 
							<ext-link ext-link-type="uri" xlink:href="http://www.mayoclinic.com/health/antidepressants/MM00660" xlink:type="simple">http://www.mayoclinic.com/health/antidepressants/MM00660</ext-link>. Accessed 22 April 2006
					</comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0030321-b8">
        <label>8</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Mintzes</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Disease mongering in drug promotion: Do governments have a regulatory role?</article-title>
          <source>PLoS Med</source>
          <year>2006</year>
          <volume>3</volume>
          <fpage>e198</fpage>
          <comment>doi: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030198" xlink:type="simple">10.1371/journal.pmed.0030198</ext-link></comment>
        </nlm-citation>
      </ref>
    </ref-list>
    
  </back>
</article>